Colchicine: A Possible COVID-19 Long haul Cardiac Therapy

February 24, 2022 | John Murphy | Leave a Comment

Colchicine: A Possible COVID-19 Long haul Cardiac Therapy

Last Updated: December 16, 2021 Last Updated: December 16, 2021 Colchicine is an anti-inflammatory drug that is used to treat a variety of conditions, including gout, recurrent pericarditis, and familial Mediterranean fever.1 Recently,…[...]

February 13, 2022 | John Murphy | Leave a Comment

Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children

Authors: Audrey Dionne, MD1,2; Francesca Sperotto, MD1,2; Stephanie Chamberlain1,2; et alAnnette L. Baker, MSN, CPNP1,2; Andrew J. Powell, MD1,2; Ashwin Prakash, MD1,2; Daniel A. Castellanos, MD1,2; Susan F. Saleeb, MD1,2; Sarah D. de Ferranti, MD, MPH1,2; Jane W. Newburger, MD, MPH1,2; Kevin G. Friedman, MD1,2 JAMA Cardiol. 2021;6(12):1446-1450. doi:10.1001/jamacardio.2021.347 Question What are the findings on cardiac imaging in children with myocarditis after COVID-19…[...]

February 13, 2022 | John Murphy | Leave a Comment

Study: Myocarditis risk 37 times higher for children with COVID-19 than uninfected peers

Authors: Melissa Jenco, News Content Editor August 31, 2021 The risk of myocarditis for children under 16 years is 37 times higher for those infected with COVID-19 than those who…[...]

February 12, 2022 | John Murphy | Leave a Comment

Former Senior FDA Official: Manufacturers, FDA Negligent In Not Investigating Covid-19 Vaccine Risks To Heart Health

Authors: DAVID GORTLER FEBRUARY 10, 2022 Manufacturers, FDA, and CDC must investigate serious cardiovascular incidents related to the Pfizer and Moderna Covid vaccines. From day ,one the U.S. Food and…[...]

February 11, 2022 | John Murphy | Leave a Comment

Long-term cardiovascular outcomes of COVID-19

Authors: Yan Xie, Evan Xu, Benjamin Bowe & Ziyad Al-Aly Nature Medicine (2022) Abstract The cardiovascular complications of acute coronavirus disease 2019 (COVID-19) are well described, but the post-acute cardiovascular manifestations of COVID-19 have not…[...]

February 10, 2022 | John Murphy | Leave a Comment

1000 Peer Reviewed Studies Questioning Covid-19 Vaccine Safety

Peer Reviewed Medical Papers Submitted To Various Medical Journals, Evidencing A Multitude Of Adverse Events In Covid-19 Vaccine Recipients. The list includes studies published as of January 20, 2022 concerning…[...]

February 10, 2022 | John Murphy | Leave a Comment

Myocarditis following mRNA vaccination against SARS-CoV-2, a case series

Authors:William W.KingaMatthew R.PetersenaRalph M.MatarbJeffery B.BudwegaLydaCuervo PardocJohn W.Petersenb American Heart Journal Plus: Cardiology Research and Practice Volume 8, August 2021, 100042 Abstract Introduction mRNA COVID-19 vaccines have emerged as a new form…[...]

January 26, 2022 | John Murphy | Leave a Comment

Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021

Authors: Matthew E. Oster, MD, MPH; David K. Shay, MD, MPH; John R. Su, MD, PhD, MPH; Julianne Gee, MPH; C. Buddy Creech, MD, MPH; Karen R. Broder, MD; Kathryn…[...]

January 6, 2022 | John Murphy | Leave a Comment

More bad news on Covid vaccines and myocarditis in men under 40 – even as more colleges require booster shots for students

Authors: Alex Berenson Reads Jan 5831 A huge new study has found the risk of serious heart problems called myocarditis in men under 40 soars with each dose of a…[...]

December 1, 2021 | John Murphy | Leave a Comment

Abstract 10712: Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning

Authors: Steven R Gundry Originally published 8 Nov 2021Circulation. 2021;144:A10712 Abstract Our group has been using the PLUS Cardiac Test (GD Biosciences, Inc, Irvine, CA) a clinically validated measurement of…[...]